Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates.

被引：0
|
作者：
Manfredini, S
Augusti, A
Durini, E
Vertuani, S
Nalin, F
Verri, A
Spadari, S
Focher, F
Solaroli, N
De Clercq, E
Balzarini, J
Ferrone, M
Pricl, S
机构：
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] CNR, Ist Genet Biochim & Evoluzionist, I-00185 Rome, Italy
[3] Huddinge Univ Hosp, Div Clin Virol, Huddinge, Sweden
[4] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[5] Univ Trieste, Dept Chem Engn, I-34127 Trieste, Italy
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
038-MEDI
引用
收藏
页码：U11 / U11
页数：1
相关论文
共 50 条
  • [31] Design and synthesis of potential 5α-reductase inhibitors for the management of benign prostaic hyperplasia
    Kumar, Rajnish
    Kumar, Manoj
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [32] Design and synthesis of a tetrahydropyran-based inhibitor of mammalian ribonucleotide reductase
    Smith, AB
    Sasho, S
    Barwis, BA
    Sprengeler, P
    Barbosa, J
    Hirschmann, R
    Cooperman, BS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) : 3133 - 3136
  • [33] Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity
    Moss, N
    Beaulieu, P
    Duceppe, JS
    Ferland, JM
    Garneau, M
    Gauthier, J
    Ghiro, E
    Goulet, S
    Guse, I
    Jaramillo, J
    LlinasBrunet, M
    Malenfant, E
    Plante, R
    Poirier, M
    Soucy, F
    Wernic, D
    Yoakim, C
    Deziel, R
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) : 4173 - 4180
  • [34] Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme
    Adane, Legesse
    Bhagat, Shweta
    Arfeen, Minhajul
    Bhatia, Sonam
    Sirawaraporn, Rachada
    Sirawaraporn, Worachart
    Chakraborti, Asit K.
    Bharatam, Prasad V.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (02) : 613 - 617
  • [35] POTENTIAL IRREVERSIBLE INHIBITORS OF RIBONUCLEOTIDE REDUCTASE - SUBSTITUTED ALPHA-(N)-HETEROCYCLIC ALDEHYDE THIOSEMICARBAZONES
    MOORE, EC
    AGRAWAL, KC
    BOOTH, BA
    SARTOREL.AC
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A908 - +
  • [36] IRON DEPRIVATION DECREASES RIBONUCLEOTIDE REDUCTASE-ACTIVITY AND DNA-SYNTHESIS
    FURUKAWA, T
    NAITOH, Y
    KOHNO, H
    TOKUNAGA, R
    TAKETANI, S
    LIFE SCIENCES, 1992, 50 (26) : 2059 - 2065
  • [37] Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase
    Cheng, Gang
    Muench, Stephen P.
    Zhou, Ying
    Afanador, Gustavo A.
    Mui, Ernest J.
    Fomovska, Alina
    Lai, Bo Shiun
    Prigge, Sean T.
    Woods, Stuart
    Roberts, Craig W.
    Hickman, Mark R.
    Lee, Patty J.
    Leed, Susan E.
    Auschwitz, Jennifer M.
    Rice, David W.
    McLeod, Rima
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 2035 - 2043
  • [38] Toward a rational design of peptide inhibitors of ribonucleotide reductase: Structure-function and modeling studies
    Pender, BA
    Wu, X
    Axelsen, PH
    Cooperman, BS
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) : 36 - 46
  • [39] Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA
    Raichurkar, AV
    Kulkarni, VM
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) : 4419 - 4427
  • [40] Antitumor activity of C-methyl-β-D-ribofuranosyladenine nucleoside ribonucleotide reductase inhibitors
    Franchetti, P
    Cappellacci, L
    Pasqualini, M
    Petrelli, R
    Vita, P
    Jayaram, HN
    Horvath, Z
    Szekeres, T
    Grifantini, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) : 4983 - 4989
12345